中枢神经系统质子调强放疗诱发的对比增强病灶:分布、动力学、危险因素与结局
该研究分析了接受至少50 Gy质子调强放疗的137例脑肿瘤患者,中位随访3年,36例(26%)出现73个放射性对比增强病灶(RICE),中位出现时间11个月。病灶多位于高剂量区(67%)和瘤床(28%),7%患者有症状,78%病灶在中位5个月后改善或消退。年龄≥18岁、肿瘤体积>30 cc及95%等剂量线重叠脑室与RICE风险升高相关。
要点
- 质子调强放疗后RICE发生率为26%,中位出现时间11个月,多位于脑室旁和高剂量区。
- 仅7%患者出现症状,78%病灶在中位5个月后改善或消退。
- 年龄≥18岁(OR 5.4)、肿瘤体积>30 cc(OR 2.8)、95%等剂量线重叠脑室(OR 3.8)与RICE风险升高相关。
核心结论
- RICE是质子调强放疗后常见的影像学发现,主要发生于脑室旁和高剂量区域,但症状性RICE不常见。
- 作者认为可考虑采用保护脑室的治疗策略以降低RICE风险。
研究设计与样本
- 回顾性分析接受至少50 Gy质子调强放疗、随访1年且治疗后完成3次磁共振扫描的脑肿瘤患者137例。
- RICE按分布分为三组:A组与肿瘤/瘤床重叠,B组位于高剂量区内或边缘(距95%等剂量线≤5 mm),C组远离高剂量区(距95%等剂量线>5 mm)。
- 对每个RICE病灶计算体素化剂量和线性能量传递(LET),采用二元逻辑回归评估危险因素。
主要发现
- 中位随访3年,137例中36例(26%)出现73个RICE病灶,中位出现时间为质子调强放疗后11个月。
- 病灶分布:A组10个(28%),B组24个(67%),C组2个(5%)。
- 10例(占总体7%)患者有症状;中位5个月后,78%的病灶改善或消退。
- RICE病灶的中位剂量为50.4 Gy,中位LET为3.1 keV/µm。
- RICE风险随年龄作为连续变量增加(每年0.4%),年龄≥18岁(比值比[OR] 5.4)、肿瘤体积>30 cc(OR 2.8)及95%等剂量线重叠脑室(OR 3.8)与风险升高相关。
临床怎么用
- 作者认为可考虑采用保护脑室的治疗策略以降低RICE风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients treated with intensity modulated proton therapy (IMPT) may develop intracranial radiation-induced contrast enhancement (RICE). The incidence, distribution, kinetics, predisposing factors, linear energy of transfer (LET) associations, and clinical outcomes of RICE are inadequately defined. METHODS AND MATERIALS: The incidence and characteristics of RICE were analyzed in brain tumor patients treated with at least 50 Gy IMPT, 1-year follow-up, and 3 posttreatment magnetic resonance imaging scans. RICE distribution was classified as overlapping with tumor/tumor bed (A), inside or marginal to high-dose region (≤5 mm from the 95% isodose line [IDL]) (B), or distant (>5 mm from 95% IDL) (C). Voxelized dose and LET were computed for each RICE lesion. Risk factors were assessed using binary logistic regression. RESULTS: With a median follow-up of 3 years, 73 RICE lesions were observed in 36 of 137 patients (26%), appearing at a median of 11 months post-IMPT. Group-wise distribution demonstrated 10 (28%), 24 (67%), and 2 (5%) lesions in groups A, B, and C, respectively. Ten (7% overall) patients were symptomatic. After a median of 5 months, most lesions (78%) improved or resolved. Median dose and LET in RICE lesions were 50.4 Gy and 3.1 keV/µm. RICE risk increased with age as a continuous variable (0.4%/year), age ≥18 years (odds ratio [OR], 5.4), tumor volume >30 cc (OR, 2.8), and 95% IDL overlapping the ventricles (OR, 3.8). CONCLUSIONS: RICE is a common radiographic finding after IMPT, primarily occurring in the periventricular and high-dose regions, but is infrequently symptomatic. Periventricular-sparing treatment may be considered to minimize the risk of RICE.
引用
- Gal O, Yu J, Mehta MP, et al. Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes. Int J Radiat Oncol Biol Phys. 2025. PMID: 40154845. doi:10.1016/j.ijrobp.2025.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。